Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 543

1.

Association of Depression With Mortality in Older Adults Undergoing Transcatheter or Surgical Aortic Valve Replacement.

Drudi LM, Ades M, Turkdogan S, Huynh C, Lauck S, Webb JG, Piazza N, Martucci G, Langlois Y, Perrault LP, Asgar AW, Labinaz M, Lamy A, Noiseux N, Peterson MD, Arora RC, Lindman BR, Bendayan M, Mancini R, Trnkus A, Kim DH, Popma JJ, Afilalo J.

JAMA Cardiol. 2018 Jan 17. doi: 10.1001/jamacardio.2017.5064. [Epub ahead of print]

PMID:
29344620
2.

The Impact of Annular Size on Outcomes After Surgical or Transcatheter Aortic Valve Replacement.

Deeb GM, Chetcuti SJ, Yakubov SJ, Patel HJ, Grossman PM, Kleiman NS, Heiser J, Merhi W, Zorn GL 3rd, Tadros PN, Petrossian G, Robinson N, Mumtaz M, Gleason TG, Huang J, Conte JV, Popma JJ, Reardon MJ.

Ann Thorac Surg. 2018 Jan 4. pii: S0003-4975(17)31229-8. doi: 10.1016/j.athoracsur.2017.08.059. [Epub ahead of print]

PMID:
29307456
3.

Comparison of everolimus-eluting bioresorbable vascular scaffolds and metallic stents: three-year clinical outcomes from the ABSORB China randomised trial

Xu B, Yang Y, Han Y, Huo Y, Wang L, Qi X, Li J, Chen Y, Kuo HC, Ying SW, Cheong WF, Zhang Y, Su X, Popma JJ, Gao R, Stone G.

EuroIntervention. 2017 Oct 22. pii: EIJ-D-17-00796. doi: 10.4244/EIJ-D-17-00796. [Epub ahead of print]

4.

Durability of quality of life benefits of transcatheter aortic valve replacement: Long-term results from the CoreValve US extreme risk trial.

Baron SJ, Arnold SV, Reynolds MR, Wang K, Deeb M, Reardon MJ, Hermiller J, Yakubov SJ, Adams DH, Popma JJ, Cohen DJ; US CoreValve Investigators.

Am Heart J. 2017 Dec;194:39-48. doi: 10.1016/j.ahj.2017.08.006. Epub 2017 Aug 12.

PMID:
29223434
5.

Complications After Self-expanding Transcatheter or Surgical Aortic Valve Replacement.

Conte JV, Hermiller J Jr, Resar JR, Deeb GM, Gleason TG, Adams DH, Popma JJ, Yakubov SJ, Watson D, Guo J, Zorn GL 3rd, Reardon MJ.

Semin Thorac Cardiovasc Surg. 2017 Autumn;29(3):321-330. doi: 10.1053/j.semtcvs.2017.06.001. Epub 2017 Jun 19.

PMID:
29195573
6.

Direct Aortic Access for Transcatheter Aortic Valve Replacement Using a Self-Expanding Device.

O'Hair DP, Bajwa TK, Popma JJ, Watson DR, Yakubov SJ, Adams DH, Sharma S, Robinson N, Petrossian G, Caskey M, Byrne T, Kleiman NS, Zhang A, Reardon MJ.

Ann Thorac Surg. 2017 Nov 21. pii: S0003-4975(17)31107-4. doi: 10.1016/j.athoracsur.2017.07.051. [Epub ahead of print]

PMID:
29174390
7.

Multi-slice Computed Tomography Assessment of Everolimus-Eluting Absorb Bioresorbable Scaffold in Comparison with Metallic Drug-Eluting Stents from the ABSORB Japan randomized Trial.

Tanabe K, Popma JJ, Kozuma K, Saito S, Muramatsu T, Nakamura S, Namiki A, Morino Y, Hagiwara N, Uematsu M, Kawasaki T, Fujii K, Serruys PW, Onuma Y, Ying S, Kusano H, Stone GW, Kimura T.

EuroIntervention. 2017 Nov 14. pii: EIJ-D-17-00716. doi: 10.4244/EIJ-D-17-00716. [Epub ahead of print]

8.

Long-Term Health Benefit of Transcatheter Aortic Valve Replacement in Patients With Chronic Lung Disease.

Crestanello JA, Popma JJ, Adams DH, Deeb GM, Mumtaz M, George B, Huang J, Reardon MJ.

JACC Cardiovasc Interv. 2017 Nov 27;10(22):2283-2293. doi: 10.1016/j.jcin.2017.07.025. Epub 2017 Nov 1.

PMID:
29102579
9.

3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial.

Kereiakes DJ, Ellis SG, Metzger C, Caputo RP, Rizik DG, Teirstein PS, Litt MR, Kini A, Kabour A, Marx SO, Popma JJ, McGreevy R, Zhang Z, Simonton C, Stone GW; ABSORB III Investigators.

J Am Coll Cardiol. 2017 Dec 12;70(23):2852-2862. doi: 10.1016/j.jacc.2017.10.010. Epub 2017 Oct 31.

PMID:
29100702
10.

Subclavian/Axillary Access for Self-Expanding Transcatheter Aortic Valve Replacement Renders Equivalent Outcomes as Transfemoral.

Gleason TG, Schindler JT, Hagberg RC, Deeb GM, Adams DH, Conte JV, Zorn GL 3rd, Hughes GC, Guo J, Popma JJ, Reardon MJ.

Ann Thorac Surg. 2017 Nov 1. pii: S0003-4975(17)31042-1. doi: 10.1016/j.athoracsur.2017.07.017. [Epub ahead of print]

PMID:
29100645
11.

Outcomes for the Commercial Use of Self-Expanding Prostheses in Transcatheter Aortic Valve Replacement: A Report From the STS/ACC TVT Registry.

Sorajja P, Kodali S, Reardon MJ, Szeto WY, Chetcuti SJ, Hermiller J Jr, Chenoweth S, Adams DH, Popma JJ.

JACC Cardiovasc Interv. 2017 Oct 23;10(20):2090-2098. doi: 10.1016/j.jcin.2017.07.027.

PMID:
29050627
12.

Maintenance of valvular integrity with Impella left heart support: Results from the multicenter PROTECT II randomized study.

Goldstein JA, Dixon SR, Douglas PS, Ohman EM, Moses J, Popma JJ, O'Neill WW.

Catheter Cardiovasc Interv. 2017 Oct 8. doi: 10.1002/ccd.27242. [Epub ahead of print]

PMID:
28988424
13.

Impact of Stent Size Selection on Acute and Long-Term Outcomes After Drug-Eluting Stent Implantation in De Novo Coronary Lesions.

Kitahara H, Okada K, Kimura T, Yock PG, Lansky AJ, Popma JJ, Yeung AC, Fitzgerald PJ, Honda Y.

Circ Cardiovasc Interv. 2017 Oct;10(10). pii: e004795. doi: 10.1161/CIRCINTERVENTIONS.116.004795.

PMID:
28951394
14.

Preparing interventional Fellows for advanced training in structural heart disease interventions.

Kalra A, Andalib A, Ramadan R, Hafiz AM, Poulin MF, Tamez H, Pinto DS, Popma JJ.

Eur Heart J. 2017 Mar 7;38(10):701-703. doi: 10.1093/eurheartj/ehx060. No abstract available.

PMID:
28938726
15.

Pathology of self-expanding transcatheter aortic valves: Findings from the CoreValve US pivotal trials.

Yahagi K, Torii S, Ladich E, Kutys R, Romero ME, Mori H, Kolodgie FD, Popma JJ, Virmani R, Finn AV.

Catheter Cardiovasc Interv. 2017 Sep 12. doi: 10.1002/ccd.27314. [Epub ahead of print]

PMID:
28895294
16.

Surgical or Transcatheter Aortic-Valve Replacement.

Reardon MJ, Van Mieghem NM, Popma JJ.

N Engl J Med. 2017 Jul 13;377(2):197-198. doi: 10.1056/NEJMc1706234. No abstract available.

PMID:
28700842
17.

Frailty in Older Adults Undergoing Aortic Valve Replacement: The FRAILTY-AVR Study.

Afilalo J, Lauck S, Kim DH, Lefèvre T, Piazza N, Lachapelle K, Martucci G, Lamy A, Labinaz M, Peterson MD, Arora RC, Noiseux N, Rassi A, Palacios IF, Généreux P, Lindman BR, Asgar AW, Kim CA, Trnkus A, Morais JA, Langlois Y, Rudski LG, Morin JF, Popma JJ, Webb JG, Perrault LP.

J Am Coll Cardiol. 2017 Aug 8;70(6):689-700. doi: 10.1016/j.jacc.2017.06.024. Epub 2017 Jul 7.

PMID:
28693934
18.

1-Year Results in Patients Undergoing Transcatheter Aortic Valve Replacement With Failed Surgical Bioprostheses.

Deeb GM, Chetcuti SJ, Reardon MJ, Patel HJ, Grossman PM, Schreiber T, Forrest JK, Bajwa TK, O'Hair DP, Petrossian G, Robinson N, Katz S, Hartman A, Dauerman HL, Schmoker J, Khabbaz K, Watson DR, Yakubov SJ, Oh JK, Li S, Kleiman NS, Adams DH, Popma JJ.

JACC Cardiovasc Interv. 2017 May 22;10(10):1034-1044. doi: 10.1016/j.jcin.2017.03.018.

PMID:
28521921
19.

A Quantitative Angiographic Comparison of Restenotic Tissue Following Placement of Drug-Eluting Stents and Bare Metal Stents in Symptomatic Patients With Femoropopliteal Disease.

Ansel GM, Jaff MR, Popma JJ, Battisti AJ, Lottes AE, Harnish P, Dake MD.

J Endovasc Ther. 2017 Aug;24(4):499-503. doi: 10.1177/1526602817708778. Epub 2017 May 9.

PMID:
28485182
20.

SUPERB final 3-year outcomes using interwoven nitinol biomimetic supera stent.

Garcia LA, Rosenfield KR, Metzger CD, Zidar F, Pershad A, Popma JJ, Zaugg M, Jaff MR; SUPERB investigators.

Catheter Cardiovasc Interv. 2017 Jun 1;89(7):1259-1267. doi: 10.1002/ccd.27058. Epub 2017 May 4.

PMID:
28471091

Supplemental Content

Loading ...
Support Center